摘要
婴幼儿血管瘤是儿童期最常见的良性肿瘤,目前主张早期予以干预,以减少并发症和对心理发育的负面影响。随着β受体阻滞剂的成功应用,治疗方法发生了革命性变化,治疗效果也随之提高。本文结合文献分析,基于循证医学证据,概述了婴幼儿血管瘤各种治疗方法的适应证、优缺点和选择依据,以期为临床应用提供指导。
Infantile hemangioma is the most common benign tumor in childhood.Early intervention is currently advocated so as to minimize complications and negative effects on mental development.With the successful application of variousβ-blockers,the treatment methods have undergone revolutionary changes,and the treatment effect has also been improved.Based on literature review and evidence-based medicine,this article summarized the indications,advantages and disadvantages and selection of various treatment methods for infantile hemangioma,in order to provide guidance for clinical application.
作者
郑家伟
赵泽亮
陈启铭
ZHENG Jia-wei;ZHAO Ze-liang;CHEN Qi-ming(Department of Oromaxillofacial Head and Neck Oncology,Shanghai Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine/College of Stomatology,Shanghai Jiao Tong University/National Center for Stomatology/National Clinical Research Center for Oral Diseases/Shanghai Key Laboratory of Stomatology.Shanghai 200011,China)
出处
《中国口腔颌面外科杂志》
CAS
2022年第1期7-14,共8页
China Journal of Oral and Maxillofacial Surgery
基金
国家自然科学基金(82071130)。
关键词
婴幼儿血管瘤
循证治疗
Β受体阻滞剂
Infantile hemangioma
Evidence-based treatment
Beta receptor blockers
作者简介
通讯作者:郑家伟(1964-),男,博士,教授,博士研究生导师,E-mail:davidzhengjw@hotmail.com。
